Patents Assigned to Children's Hospital
-
Patent number: 11883230Abstract: A transcranial scanning device and method of use is disclosed. The transcranial scanning device is for identifying a neurologic-injury-mechanism and comprises a sensing wand comprising a transducer that produces and receives sound waves. The sensing wand is passed over a head of a patent with cerebral malaria, and sound waves reflect off of blood cells in blood vessels in the head of the patient creating an output sound wave responsive to a blood flow of the patient. The output sound wave is received by the transducer. An output screen coupled to the sensing wand, displays in real time an output waveform corresponding to the output sound wave, wherein the output waveform is indicative of one or more symptoms of cerebral malaria, and wherein said symptoms identify one or more neurologic-injury-mechanism occurring within the patient.Type: GrantFiled: September 18, 2018Date of Patent: January 30, 2024Assignee: The Research Institute at Nationwide Children's HospitalInventor: Nicole Fortier O'Brien
-
Publication number: 20240027460Abstract: The present disclosure relates to biomarker profiles and their use to predict a subject's response to an immunomodulatory treatment. Biomarkers in these profiles include cytokines and other proteins associated with the interleukin 1 family and the type 1 interferon family. Particular biomarkers include interleukin (IL)-2, soluble IL-2 receptor alpha (sIL-2RA), IL-5, IL-6, IL-9, IL-10, IL-18, IL-18 binding protein (IL-18BP), IL-18 receptor 1 (IL-18R1), IL-18 receptor accessory protein (IL-18RAP), IL-22, C-type lectin-like receptor (CD161), CD56, interferon gamma (IFN?), granulocyte macrophage colony stimulating factor (GM-CSF), serum amyloid A (SAA), and C-reactive protein (CRP). Particular biomarkers also include populations of cells including CD161+ cells and CD56+dim cells. The biomarker profiles can be used to predict a subject's responsiveness to an immunomodulatory treatment (e.g.Type: ApplicationFiled: November 19, 2021Publication date: January 25, 2024Applicants: Seattle Children's Hospital d/b/a Seattle Children's Research Institute, Battelle Memorial InstituteInventors: Heather Gustafson, Rebecca Gardner, Bobbie-Jo M. Webb-Robertson, Katelyn Burleigh
-
Patent number: 11878056Abstract: Methods for preparing highly purified AAV vector formulations are provided. The highly pure AAV formulations described herein are superior for clinical use.Type: GrantFiled: September 10, 2020Date of Patent: January 23, 2024Assignee: THE CHILDREN'S HOSPITAL OF PHILADELPHIAInventors: John Fraser Wright, Guang Qu, Bernd Hauck, Katherine A. High
-
Publication number: 20240021097Abstract: A system and method for predicting risk of violence for an individual (primarily school violence, but not limited to school violence) performs the following steps: (a) receiving responses to questions from an individual; (b) extracting by a computerized annotator words or phrases from the questions and responses; (c) assigning by the annotator extracted word(s) or phrase(s) to at least one of a plurality of pre-defined categories; and (d) automatically identifying and scoring words or phrases that could be classified into the pre-defined categories by a trained machine-learning engine to produce a score reflecting relative risk of violence by the individual. The pre-defined categories include: expression of violent acts or thoughts of the individual; expression of negative feelings, thoughts or acts of others; expression of negative feelings, thoughts or acts of the individual; expression of family discord or tragedies; and expression of protective factors.Type: ApplicationFiled: August 4, 2023Publication date: January 18, 2024Applicant: Children's Hospital Medical CenterInventors: Drew BARZMAN, Yizhao NI
-
Publication number: 20240018471Abstract: Provided herein are engineered red blood cells expressing rare blood antigen group profiles, and methods of making use the same, are described. Also provided are recombinant reagent red blood cells that express or lack the expression of at least one protein (e.g., a blood group antigen) on its surface and uses thereof.Type: ApplicationFiled: June 6, 2023Publication date: January 18, 2024Applicants: THE CHILDREN'S HOSPITAL OF PHILADELPHIA, NEW YORK BLOOD CENTER, INC.Inventors: Stella CHOU, Connie WESTHOFF
-
Publication number: 20240004969Abstract: Examples are described for dynamically applying a digital watermark to a file, such as a dataset of genomic sequencing data. In one example, a method of dynamically applying a watermark to at least a portion of a file includes generating a first random seed, generating an ordered pseudorandom set of integers, generating a second random seed, selecting, using the second random seed, a subset of the ordered pseudorandom set of integers, the subset corresponding to identifiers of data locations in the file, and modifying data at data locations in the file corresponding to at least a portion of the identifiers included in the subset to generate a watermarked file. The genomic data file may be an ordered Binary Alignment Map (BAM) file storing sequencing data or a Variant Call Format (VCF) file or a list of variants storing genomic variation data.Type: ApplicationFiled: April 21, 2021Publication date: January 4, 2024Applicants: Children's Hospital Los Angeles, University of Southern CaliforniaInventors: Xiaowu Gai, Alex Ryutov, Tatyana Ryutov
-
Publication number: 20240005496Abstract: A method for determining a presence of arthritis in a patient, including obtaining a first image of a patient's joint, wherein the first image is a visible light image, obtaining a second image of the patient's joint, wherein the second image is a thermal light image, determining an outline of the patient's joint from the first image, determining an outline of a reference area from the first image, wherein the patient's joint is adjacent to the reference area, determining a first representative topological temperature within the outline of the patient's joint of the first image from the second image, determining a second representative topological temperature within the outline of the reference area of the first image from the second image, comparing the first representative topological temperature and the second representative topological temperature; and determining a likelihood of the presence of arthritis within the patient's joint.Type: ApplicationFiled: June 28, 2023Publication date: January 4, 2024Applicants: Seattle Children's Hospital dba Seattle Children's Research Institute, University of WashingtonInventors: Yongdong Zhao, Joshua Scheck, Savannah Corrina Partridge, Ramesh S. Iyer, Mahesh Thapa, Debosmita Biswas, Sr., Nivrutti Vasudev Bhide, Kevin Charles Cain, Jason Michael Pyke
-
Publication number: 20240003904Abstract: Methods and compositions disclosed herein generally relate to methods of identifying, validating, and measuring clinically relevant, quantifiable biomarkers of diagnostic and therapeutic responses for blood, vascular, cardiac, and respiratory tract dysfunction, particularly as those responses relate to persistent multiple organ dysfunction syndrome (MODS) in pediatric patients following cardiopulmonary bypass (CPB). Certain aspects of the disclosure relates to identifying one or more biomarkers associated with septic shock in pediatric patients, obtaining one or more samples from a pediatric patient following CPB, then quantifying from the sample an amount of said biomarkers, wherein the level of said biomarker correlates with a predicted outcome.Type: ApplicationFiled: May 30, 2023Publication date: January 4, 2024Applicant: Children's Hospital Medical CenterInventor: Hector R. Wong
-
Patent number: 11859250Abstract: The present invention relates to methods for identifying an EoE endotype of a patient and treating the patient with one or more therapies targeted to the patient's disease endotype; and related methods for stratifying patients for clinical trials.Type: GrantFiled: February 21, 2019Date of Patent: January 2, 2024Assignee: CHILDREN'S HOSPITAL MEDICAL CENTERInventors: Marc E. Rothenberg, Tetsuo Shoda, Ting Wen
-
Patent number: 11860161Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.Type: GrantFiled: August 5, 2019Date of Patent: January 2, 2024Assignee: Seattle Children's HospitalInventors: Neelufar Mozaffarian, Anne M. Stevens
-
Publication number: 20230414611Abstract: Identification of Fragile X syndrome (FXS) patients who are likely to respond to a treatment involving a GABAA receptor modulator (e.g., a selective GABAA receptor stimulator), for example, at a low dose, using peripheral Fragile X mental retardation protein (FMRP) as a biomarker, either taken alone or in combination with other biomarkers. Also provided here are methods for treating such FXS patients using the GABAA receptor modulator (e.g., a selective GABAA receptor stimulator at a low dose).Type: ApplicationFiled: November 12, 2021Publication date: December 28, 2023Applicant: CHILDREN'S HOSPITAL MEDICAL CENTERInventors: Craig A. ERICKSON, Christina GROSS, Ernest PEDAPATI, Lauren SCHMITT
-
Publication number: 20230414766Abstract: Provided are macromolecular prodrugs in which camptothecin analogs are covalently bonded to polymers via ester bonds that are labile under physiological conditions. Also provided are methods of treating cancer, especially neuroblastoma with the macromolecular prodrugs.Type: ApplicationFiled: April 27, 2023Publication date: December 28, 2023Applicant: The Children's Hospital of PhiladelphiaInventors: Michael Chorny, Ivan Alferiev, Garrett M. Brodeur
-
Patent number: 11851649Abstract: Aspects of the invention described herein relate to methods of making and using inducible promoters for transgene expression. The inducible promoters are derived from the NFAT-RE inducible system and are used to improve or enhance T cell survival and proliferation.Type: GrantFiled: May 15, 2018Date of Patent: December 26, 2023Assignee: Seattle Children's HospitalInventors: Jia Wei, Michael C. Jensen
-
Publication number: 20230407334Abstract: Some embodiments of the invention include pseudotyped particles (e.g., pseudo typed exosomes, pseudotyped VSV, and pseudo typed lentiviruses) and modified cells. Other embodiments of the invention include compositions (e.g., pharmaceutical compositions) of pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) and modified cells. Certain embodiments of the invention include methods of making pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) and modified cells. Other embodiments of the invention include methods of administering pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses). Further embodiments of the invention include methods of administering pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) to treat diseases (e.g., muscular dystrophy). Additional embodiments of the invention are also discussed herein.Type: ApplicationFiled: October 30, 2021Publication date: December 21, 2023Applicant: CHILDREN'S HOSPITAL MEDICAL CENTERInventors: Douglas MILLAY, Sajedah HINDI
-
COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM
Publication number: 20230406911Abstract: Provided are methods for one or more of the following: preventing, inhibiting, disrupting, dispersing or treating a polymicrobial biofilm comprising a Haemophilus bacteria in vitro and/or in vivo, such as in a subject in need thereof. The method comprises or consists essentially of, or yet further consists of contacting the polymicrobial biofilm with: (i) an anti DNA binding and bending protein (DNABII) antibody or a biologically active fragment thereof; and (ii) an anti majority subunit (PilA) of type IV pilus (T4P) antibody or a biologically active fragment thereof. Additionally, the methods may further comprise contacting the polymicrobial biofilm with an antibiotic optionally comprising a ?-lactam antibiotic or a sulfonamide antibiotic. Also provided are compositions and kits suitable for use in the methods.Type: ApplicationFiled: November 1, 2021Publication date: December 21, 2023Applicant: RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITALInventors: Lauren O. Bakaletz, Steven D. Goodman -
Publication number: 20230407399Abstract: Compositions and methods for the detection and treatment of ADHD are provided.Type: ApplicationFiled: March 7, 2023Publication date: December 21, 2023Applicant: THE CHILDREN'S HOSPITAL OF PHILADELPHIAInventors: Joseph Glessner, Josephine Elia, Hakon Hakonarson
-
Patent number: 11844600Abstract: A patient table adapted for use in association with an MR scanner for neonatal infants is provided. The patient table has an extendable patient bed attached to and extendable from the patient table. The patient bed may be at least partially inserted into an MR scanner without requiring the patient table to enter the MR scanner. A transport mechanism is on the underside of the patient table so that it may be readily moved over the floor on which it rests. The patient table includes a latching mechanism that may operate to releasably attach the patient table to a patient table docking assembly. The docking assembly is operative to selectively move the patient table towards, into and away from the MR scanner.Type: GrantFiled: May 17, 2021Date of Patent: December 19, 2023Assignee: CHILDREN'S HOSPITAL MEDICAL CENTERInventor: Charles L Dumoulin
-
Patent number: 11845935Abstract: Some embodiments of the invention include a nucleic acid molecule comprising natural nucleotides, non-natural nucleotides, an LNA which comprises one or more RNA core molecules, or an RNA molecule which comprises more than one RNA core molecule. Some embodiments of the invention include a nucleic acid molecule comprising an RNA molecule which comprises more than one RNA core molecule. Other embodiments of the invention include a nucleic acid molecule comprising a DNA molecule encoding the RNA molecule (e.g., vector or viral vector). Other embodiments include compositions or pharmaceutical compositions that comprise the nucleic acid molecule. Some embodiments of the invention comprise reducing miR-143 in a cell. Other embodiments of the invention include methods to deliver a protein across the BBB. Other embodiments include methods for treating disease (e.g., LSD, neuronopathic disease, neurodegenerative disease, Hurler syndrome, or MPS I). Additional embodiments of the invention are also discussed herein.Type: GrantFiled: March 29, 2018Date of Patent: December 19, 2023Assignee: CHILDREN'S HOSPITAL MEDICAL CENTERInventor: Dao Pan
-
Publication number: 20230398238Abstract: A liposomal composition (“ADx-003”) is provided, ADx-003 comprising a first phospholipid; a sterically bulky excipient that is capable of stabilizing the liposomal composition; a second phospholipid that is derivatized with a first polymer; a macrocyclic gadolinium-based imaging agent; and a third phospholipid that is derivatized with a second polymer, the second polymer being conjugated to a targeting ligand, the targeting ligand being represented by Formula I: wherein X is —CH2—, —CH2—CH2—, —CHO—, or —O—CO—; Y is —CH—CH?CH— or A and B are independently selected from C and N; R1, R2, R3, and R4 are independently selected from —H, halogen, —OH, and —CH3; and R5, R6, and R7 are independently selected from —H, halogen, —OH, —OCH3, —NO2, —N(CH3)2, C1-C6 alkyl, or a substituted or unsubstituted C4-C6 aryl group, except that when A and/or B is N the adjacent R5 and/or R7 is —H, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: August 24, 2023Publication date: December 14, 2023Applicants: Texas Children's Hospital, Alzeca Biosciences, LLCInventors: Eric A. Tanifum, Xianwei Sun, Ananth V. Annapragada, Carlo Medici
-
Patent number: 11840683Abstract: A glomerulus on a chip (GOAC) to recapitulate the human glomerular filtration barrier, the structure responsible for filtering the blood and preventing the loss of proteins, is provided using human podocytes and glomerular endothelial cells seeded into microfluidic chips. In long-term cultures, cells maintain their morphology, form capillary-like structures and express slit diaphragm proteins. This system recapitulates functions and structure of the glomerulus, including permselectivity. When exposed to sera from patients with anti-podocyte autoantibodies, the chips show albuminuria proportional to patients' proteinuria, phenomenon not observed with sera from healthy controls or individuals with primary podocyte defects. Also shown is its applicability for renal disease modeling and drug testing.Type: GrantFiled: May 8, 2020Date of Patent: December 12, 2023Assignee: Children's Hospital Los AngelesInventors: Laura Perin, Stefano Da Sacco, Roger De Filippo